$115.0 million syndicated ABL facility retired by a new $200 million term facility; ABL facility advanced 85% on eligible A/R plus up to $20 million of eligible cash and included a FCCR covenant
Share this post
L.O.T.W. #131 - Myriad Genetics exits the…
Share this post
$115.0 million syndicated ABL facility retired by a new $200 million term facility; ABL facility advanced 85% on eligible A/R plus up to $20 million of eligible cash and included a FCCR covenant